+ All Categories
Home > Documents > Q&A With The Joint Commisson...Robert Campbell, PharmD Director, Clinical Standards Interpretation...

Q&A With The Joint Commisson...Robert Campbell, PharmD Director, Clinical Standards Interpretation...

Date post: 24-Aug-2021
Category:
Upload: others
View: 2 times
Download: 0 times
Share this document with a friend
40
Q&A With The Joint Commission COVID-19 Webinar for Home Care Accreditation August 20, 2020
Transcript
Page 1: Q&A With The Joint Commisson...Robert Campbell, PharmD Director, Clinical Standards Interpretation Hospital / Ambulatory Programs Director, Medication Management The Joint Commission

Q&A With The Joint CommissionCOVID-19 Webinar for Home Care Accreditation

August 20, 2020

Page 2: Q&A With The Joint Commisson...Robert Campbell, PharmD Director, Clinical Standards Interpretation Hospital / Ambulatory Programs Director, Medication Management The Joint Commission

© 2020 The Joint Commission. All Rights Reserved.

2

SpeakersRobert Campbell, PharmD Director, Clinical Standards InterpretationHospital / Ambulatory Programs Director, Medication Management The Joint Commission

Herman A. McKenzie, MBA, CHSP Director of Engineering, Standards Interpretation Group (SIG) Division of Healthcare Improvement The Joint Commission

Kelly McCannAssociate Director, AccreditationThe Joint Commission

Jennifer WelchAssociate Director, AccreditationThe Joint Commission

Kathy ValenciaField DirectorThe Joint Commission

Deborah Ryan, MS, RNSenior Director, Field OperationsThe Joint Commission

Wayne MurphyField DirectorThe Joint Commission

Sylvia Garcia-Houchins, MBA, RN, CICDirector, Infection Prevention and ControlThe Joint Commission

Maura Naddy, MSN, RNC-OBAssociate Director Standards InterpretationThe Joint Commission

Mark MillerAssociate Director, StandardsInterpretation GroupThe Joint Commission

Page 3: Q&A With The Joint Commisson...Robert Campbell, PharmD Director, Clinical Standards Interpretation Hospital / Ambulatory Programs Director, Medication Management The Joint Commission

3

© 2019 The Joint Commission. All Rights Reserved.

The Joint Commission Return to Survey Activity

−In addition to conducting accreditation surveys, we have been advocating for the safety and well-being of healthcare workers at the highest levels of policy making.

−We want to assure you that we want to work together to reduce your risk and ours during the on-site survey process.

Page 4: Q&A With The Joint Commisson...Robert Campbell, PharmD Director, Clinical Standards Interpretation Hospital / Ambulatory Programs Director, Medication Management The Joint Commission

4

© 2019 The Joint Commission. All Rights Reserved.

Your QuestionsYou have had a number of questions about our return to survey:

−How or when will we get a survey?−What will that survey process look like, any differences?−What type of instructions have you provided your

surveyors?−What will the surveyors focus on?

Page 5: Q&A With The Joint Commisson...Robert Campbell, PharmD Director, Clinical Standards Interpretation Hospital / Ambulatory Programs Director, Medication Management The Joint Commission

5

© 2019 The Joint Commission. All Rights Reserved.

When and how will survey activity resume?− Survey activity has started in low risk areas – includes all programs− Low risk criteria− Number of COVID-19 cases are lower and less impact to organizations− The # of cases/thousand population and new cases within the county− Determination that our staff can travel to that area safely and find

appropriate accommodations. − In addition, your Account Executive will contact you to determine your

readiness. − We are aware that surveys are past their due dates, we will conduct those

surveys when we are able. − Prioritized initials and past due organizations. We will also be looking for

organizations due in the next few months that meet the low risk criteria and are currently ready for survey.

Page 6: Q&A With The Joint Commisson...Robert Campbell, PharmD Director, Clinical Standards Interpretation Hospital / Ambulatory Programs Director, Medication Management The Joint Commission

6

© 2019 The Joint Commission. All Rights Reserved.

What instructions have been provided to surveyors?

− Do not travel if you are sick− Do not travel if you have been in close contact with known or suspected

COVID-19 patients− When traveling you are required to wear a mask/face covering− You are required to wear a mask on survey and follow the

organization’s guidelines. The organization will provide the PPE to the surveyor as required by their policy.

− Practice physical distancing− Practice good hand hygiene− Follow CDC guidelines

Page 7: Q&A With The Joint Commisson...Robert Campbell, PharmD Director, Clinical Standards Interpretation Hospital / Ambulatory Programs Director, Medication Management The Joint Commission

7

© 2019 The Joint Commission. All Rights Reserved.

What has changed about the survey process?The survey process and its components will remain the same, however here are some guidelines for the survey/ review:−Limit the number of individuals in group sessions−Use audio or video conferencing to safely expand the number of

attendees for sessions−Make the use of masks a routine practice−Maximize the use of technology to eliminate the number of people

needed to sit directly next to an individual for an extended period of time. For example, screen sharing or projecting medical records.

Page 8: Q&A With The Joint Commisson...Robert Campbell, PharmD Director, Clinical Standards Interpretation Hospital / Ambulatory Programs Director, Medication Management The Joint Commission

8

© 2019 The Joint Commission. All Rights Reserved.

Survey/Review Process - Continued− We will NOT enter an at risk or confirmed COVID-19 room. We will not

visit a unit with any confirmed COVID-19 patients. − Limited physical review of high risk and aerosol generating procedures− Consider using a simulation and/or distant review of certain

activities/procedures− Practice social/physical distancing during the survey− Follow “PPE” and risk reduction strategies as established by the CDC− Limit attendance at group sessions (e.g., opening, briefings, system

tracers)− Limit observers or scribes to avoid additional exposure during the

survey

Page 9: Q&A With The Joint Commisson...Robert Campbell, PharmD Director, Clinical Standards Interpretation Hospital / Ambulatory Programs Director, Medication Management The Joint Commission

9

© 2019 The Joint Commission. All Rights Reserved.

Additional Information− We would ask that you do not provide additional avoid dates due to the

difficulty in scheduling surveys – avoid dates already submitted will be honored to the extent we can

− Virtual surveys – early surveys and initial surveys have occurred in some programs

− Virtual event is a combination of:−Secure Zoom technology for the survey and facility review −Use of a secure SharePoint site for document upload to review

presurvey− Initial surveys conducted virtually will have a follow-up survey on-site. −Organization is contacted to verify ability and willingness to

participate

Page 10: Q&A With The Joint Commisson...Robert Campbell, PharmD Director, Clinical Standards Interpretation Hospital / Ambulatory Programs Director, Medication Management The Joint Commission

10

© 2019 The Joint Commission. All Rights Reserved.

COVID-19 Resources

Page 11: Q&A With The Joint Commisson...Robert Campbell, PharmD Director, Clinical Standards Interpretation Hospital / Ambulatory Programs Director, Medication Management The Joint Commission

11© 2020 Joint Commission Resources. All Rights Reserved.

Home Care Executive Briefings Program: Live, Virtual Event (2-half days)

Date: October 26 and October 27, 2020SKU: EDU2016Price: $499.00URL: https://store.jcrinc.com/home-care-executive-briefing-live-virtual-event-october-26-27-2020/

Who Should Attend? Any healthcare professional that is accredited by Joint Commission’s accreditation standards related to Home Care.

What Will You Learn? Program agenda and objectives in development that will be posted on JCR website in the near future.

Page 12: Q&A With The Joint Commisson...Robert Campbell, PharmD Director, Clinical Standards Interpretation Hospital / Ambulatory Programs Director, Medication Management The Joint Commission

© 2020 The Joint Commission. All Rights Reserved.

Pre-Submitted Questions

Other pre-submitted questions...

Page 13: Q&A With The Joint Commisson...Robert Campbell, PharmD Director, Clinical Standards Interpretation Hospital / Ambulatory Programs Director, Medication Management The Joint Commission

© 2020 The Joint Commission. All Rights Reserved.

Pre-Submitted Questions

Can we do tele-visit for an initial assessment??

Page 14: Q&A With The Joint Commisson...Robert Campbell, PharmD Director, Clinical Standards Interpretation Hospital / Ambulatory Programs Director, Medication Management The Joint Commission

© 2020 The Joint Commission. All Rights Reserved.

Pre-Submitted Questions

What is the guidance regarding telehealth vs. face to face encounters?

Page 15: Q&A With The Joint Commisson...Robert Campbell, PharmD Director, Clinical Standards Interpretation Hospital / Ambulatory Programs Director, Medication Management The Joint Commission

© 2020 The Joint Commission. All Rights Reserved.

Pre-Submitted Questions

Management of both virtual and in-person visits in the HH and HO Plans of Care?

Page 16: Q&A With The Joint Commisson...Robert Campbell, PharmD Director, Clinical Standards Interpretation Hospital / Ambulatory Programs Director, Medication Management The Joint Commission

© 2020 The Joint Commission. All Rights Reserved.

Pre-Submitted Questions

For hospice continuous care, due to difficulty in staffing, can we include telehealth services to fill in gaps for continuous care?

Page 17: Q&A With The Joint Commisson...Robert Campbell, PharmD Director, Clinical Standards Interpretation Hospital / Ambulatory Programs Director, Medication Management The Joint Commission

© 2020 The Joint Commission. All Rights Reserved.

Pre-Submitted Questions

How has COVID-19 affected areas such as QAPI and use of volunteers?

Page 18: Q&A With The Joint Commisson...Robert Campbell, PharmD Director, Clinical Standards Interpretation Hospital / Ambulatory Programs Director, Medication Management The Joint Commission

© 2020 The Joint Commission. All Rights Reserved.

Pre-Submitted Questions

In Florida, are supervisory visits of HHA/CNA, LPN allowed to be done virtually during the pandemic/ COVID19?

Page 19: Q&A With The Joint Commisson...Robert Campbell, PharmD Director, Clinical Standards Interpretation Hospital / Ambulatory Programs Director, Medication Management The Joint Commission

© 2020 The Joint Commission. All Rights Reserved.

Pre-Submitted Questions

In relation to the COVID-19 pandemic do all policies have to be revised individually to address changes or will the emergency operations plan take care of identifying all change such as infection control, environment of care?

Page 20: Q&A With The Joint Commisson...Robert Campbell, PharmD Director, Clinical Standards Interpretation Hospital / Ambulatory Programs Director, Medication Management The Joint Commission

© 2020 The Joint Commission. All Rights Reserved.

Pre-Submitted Questions

When will you be surveying for hospice deemed status, will you expect we catch up on all the waived items? For example, 12 hours HHA, QAPI meeting, PI projects etc, or just for the months after the waiver is over?

Page 21: Q&A With The Joint Commisson...Robert Campbell, PharmD Director, Clinical Standards Interpretation Hospital / Ambulatory Programs Director, Medication Management The Joint Commission

© 2019 The Joint Commission. All Rights Reserved.

21

Pre-Submitted Questions

Can you comment on whether home care personnel can wear a face covering instead of PPE if they require the patient and any others present during the visit to wear a face covering?

Page 22: Q&A With The Joint Commisson...Robert Campbell, PharmD Director, Clinical Standards Interpretation Hospital / Ambulatory Programs Director, Medication Management The Joint Commission

© 2019 The Joint Commission. All Rights Reserved.

22

Pre-Submitted Questions

What is the difference between a face covering and PPE?

Page 23: Q&A With The Joint Commisson...Robert Campbell, PharmD Director, Clinical Standards Interpretation Hospital / Ambulatory Programs Director, Medication Management The Joint Commission

© 2019 The Joint Commission. All Rights Reserved.

23

Pre-Submitted Questions

When should home care personnel be wearing PPE? For example, what should be worn when caring for a patient who is not known to be infected with COVID in the home health setting?

Page 24: Q&A With The Joint Commisson...Robert Campbell, PharmD Director, Clinical Standards Interpretation Hospital / Ambulatory Programs Director, Medication Management The Joint Commission

© 2019 The Joint Commission. All Rights Reserved.

24

Pre-Submitted Questions

Do personnel entering the home need to wear a new face covering, mask, or respirator every time they do a home visit?

Page 25: Q&A With The Joint Commisson...Robert Campbell, PharmD Director, Clinical Standards Interpretation Hospital / Ambulatory Programs Director, Medication Management The Joint Commission

© 2019 The Joint Commission. All Rights Reserved.

25

Pre-Submitted Questions

If in home clients tell their caregivers they do not need to wear masks or they do not want them to wear masks, can home care employers require them to wear masks?

Page 26: Q&A With The Joint Commisson...Robert Campbell, PharmD Director, Clinical Standards Interpretation Hospital / Ambulatory Programs Director, Medication Management The Joint Commission

© 2019 The Joint Commission. All Rights Reserved.

26

Pre-Submitted Questions

We are trying to weigh patient rights with current infection control recommendations. Are patients allowed to choose not to wear masks during home visits with staff even though the mask is not contradicted? What do we do if they refuse?

Page 27: Q&A With The Joint Commisson...Robert Campbell, PharmD Director, Clinical Standards Interpretation Hospital / Ambulatory Programs Director, Medication Management The Joint Commission

© 2019 The Joint Commission. All Rights Reserved.

27

Pre-Submitted Questions

What is a company supposed to do when they can't get any more N95 masks?

Page 28: Q&A With The Joint Commisson...Robert Campbell, PharmD Director, Clinical Standards Interpretation Hospital / Ambulatory Programs Director, Medication Management The Joint Commission

© 2019 The Joint Commission. All Rights Reserved.

28

Pre-Submitted Questions

Human Resource would like to know what factors are important to evaluate possible transmission between employees?

OSHA: https://www.osha.gov/memos/2020-05-19/revised-enforcement-guidance-recording-cases-coronavirus-disease-2019-covid-19

Page 29: Q&A With The Joint Commisson...Robert Campbell, PharmD Director, Clinical Standards Interpretation Hospital / Ambulatory Programs Director, Medication Management The Joint Commission

© 2019 The Joint Commission. All Rights Reserved.

29

Pre-Submitted Questions

Should Home Care personnel be tested for COVID before making home visits? And if yes, how often?

Page 30: Q&A With The Joint Commisson...Robert Campbell, PharmD Director, Clinical Standards Interpretation Hospital / Ambulatory Programs Director, Medication Management The Joint Commission

© 2019 The Joint Commission. All Rights Reserved.

30

Pre-Submitted Questions

What does The Joint Commission require if an RN's family member has tested positive for COVID-19, and the RN denies any symptoms? Can the RN continue to work?

CDC Guidance: https://www.cdc.gov/coronavirus/2019-ncov/hcp/guidance-risk-assesment-hcp.html

Page 31: Q&A With The Joint Commisson...Robert Campbell, PharmD Director, Clinical Standards Interpretation Hospital / Ambulatory Programs Director, Medication Management The Joint Commission

© 2019 The Joint Commission. All Rights Reserved.

31

Pre-Submitted Questions

Is every discipline required to screen the patient for COVID-19 symptoms if they are seeing the patient on the same day? The same week?

Page 32: Q&A With The Joint Commisson...Robert Campbell, PharmD Director, Clinical Standards Interpretation Hospital / Ambulatory Programs Director, Medication Management The Joint Commission

© 2019 The Joint Commission. All Rights Reserved.

32

Pre-Submitted Questions

Does The Joint Commission have guidance regarding shortages in hand hygiene products, cleaning and disinfecting supplies?

FDA Resource: Hand sanitizers https://www.fda.gov/drugs/coronavirus-covid-19-drugs/hand-sanitizers-covid-19EPA Disinfectants: https://www.epa.gov/pesticide-registration/list-n-disinfectants-use-against-sars-cov-2-covid-19

Page 33: Q&A With The Joint Commisson...Robert Campbell, PharmD Director, Clinical Standards Interpretation Hospital / Ambulatory Programs Director, Medication Management The Joint Commission

© 2019 The Joint Commission. All Rights Reserved.

33

Pre-Submitted Questions

We provide Life-Support Ventilators and other equipment to patients at home.

What measures should we be taking to insure our equipment is properly sanitized other than wiping down with disinfecting wipes?

Page 34: Q&A With The Joint Commisson...Robert Campbell, PharmD Director, Clinical Standards Interpretation Hospital / Ambulatory Programs Director, Medication Management The Joint Commission

© 2019 The Joint Commission. All Rights Reserved.

34

Pre-Submitted Questions

Client remains positive after repeated swabs, with other referral sources refusing to accept patient. Do we test once, let the 10-14 days elapse and consider the client 'negative' once symptoms abate, something else?

CDC Guidance: Clinical Questions about COVID-19: Questions and Answers: Patients with Persistent or Recurrent Positive Tests https://www.cdc.gov/coronavirus/2019-ncov/hcp/faq.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019-ncov%2Fhcp%2Finfection-control-faq.html#Patients-with-Persistent-or-Recurrent-Positive-Tests

Page 35: Q&A With The Joint Commisson...Robert Campbell, PharmD Director, Clinical Standards Interpretation Hospital / Ambulatory Programs Director, Medication Management The Joint Commission

© 2019 The Joint Commission. All Rights Reserved.

35

Pre-Submitted Questions

What would surveyors be looking for with regards to COVID positive patients being cared for by our agency and staff who have tested positive for COVID?

Page 36: Q&A With The Joint Commisson...Robert Campbell, PharmD Director, Clinical Standards Interpretation Hospital / Ambulatory Programs Director, Medication Management The Joint Commission

© 2019 The Joint Commission. All Rights Reserved.

36

Pre-Submitted Questions

What IC plan updates or policy & procedures are required for COVID-19?

Page 37: Q&A With The Joint Commisson...Robert Campbell, PharmD Director, Clinical Standards Interpretation Hospital / Ambulatory Programs Director, Medication Management The Joint Commission

© 2019 The Joint Commission. All Rights Reserved.

37

Pre-Submitted Questions

Does The Joint Commission have specific infection control protocols for COVID-19 that apply to the office, retail, or home environment?CDC Guidance: Community, Work, and School https://www.cdc.gov/coronavirus/2019-ncov/community/index.htmlInterim Guidance for Implementing Home Care of People Not Requiring Hospitalization for Coronavirus Disease 2019 (COVID-19)https://www.cdc.gov/coronavirus/2019-ncov/hcp/guidance-home-care.html

Page 38: Q&A With The Joint Commisson...Robert Campbell, PharmD Director, Clinical Standards Interpretation Hospital / Ambulatory Programs Director, Medication Management The Joint Commission

© 2019 The Joint Commission. All Rights Reserved.

38

Pre-Submitted Questions

We currently follow the guidelines of OSHA and the Puerto Rico Department of Health, what other preventive measures must be taken to comply with TJC?

Page 39: Q&A With The Joint Commisson...Robert Campbell, PharmD Director, Clinical Standards Interpretation Hospital / Ambulatory Programs Director, Medication Management The Joint Commission

© 2020 The Joint Commission. All Rights Reserved.

Thank You

We support your efforts in response to the COVID-19 pandemic and hope to provide helpful resources

Page 40: Q&A With The Joint Commisson...Robert Campbell, PharmD Director, Clinical Standards Interpretation Hospital / Ambulatory Programs Director, Medication Management The Joint Commission

© 2020 The Joint Commission. All Rights Reserved.

Resources−COVID Resources− https://www.jointcommission.org/covid-19/

−Standards Interpretation− https://www.jointcommission.org/standards/standard-

faqs/


Recommended